Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm

被引:44
作者
Forner, Alejandro [1 ,4 ]
Vilana, Ramon [2 ,4 ]
Bianchi, Luis [2 ,4 ]
Rodriguez-Lope, Carlos [1 ]
Reig, Maria [1 ,4 ]
Angeles Garcia-Criado, M. [2 ]
Rimola, Jordi [2 ,4 ]
Sole, Manel [3 ,4 ]
Ayuso, Carmen [2 ,4 ]
Bru, Concepcio [2 ,4 ]
Bruix, Jordi [1 ,4 ]
机构
[1] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Liver Unit,Barcelona Clin Liver Canc BCLC Grp, E-08007 Barcelona, Spain
[2] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Radiol Dept,Barcelona Clin Liver Canc BCLC Grp, E-08007 Barcelona, Spain
[3] Univ Barcelona, IDIBAPS, Hosp Clin Barcelona, Pathol Dept,Barcelona Clin Liver Canc BCLC Grp, E-08007 Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain
关键词
Hepatocellular carcinoma; Contrast-enhanced ultrasonography; Cirrhosis; Dynamic imaging techniques; Diagnosis; EARLY HEPATOCELLULAR-CARCINOMA; CLINICAL-PRACTICE GUIDELINES; RADIOFREQUENCY ABLATION; CIRRHOSIS; MANAGEMENT; CHOLANGIOCARCINOMA; RECOMMENDATIONS; RESECTION; PATTERNS; CRITERIA;
D O I
10.1016/j.jhep.2014.08.028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Current guidelines recommend diagnostic work-up for nodules >1 cm detected during screening for hepatocellular carcinoma (HCC). This implies that patients with benign conditions may undergo unnecessary evaluation and those with small nodules may be intervened too early, leading to overdiagnosis. Since increased arterial vascularization is the hallmark of malignancy, its detection by contrast-enhanced ultrasound (CEUS) could become the signal to proceed with diagnosis confirmation. The aim was to assess if HCCs <2 cm without arterial hyperenhancement by baseline CEUS have a benign evolutionary profile, suggesting that diagnosis and invasive treatment could be delayed until detection of an overt malignant profile, associated with increased vascularization. Methods: We prospectively included 168 cirrhotic patients with a newly detected solitary nodule of 5-20 mm by screening ultrasonography. MRI, CEUS and fine needle biopsy (FNB) were performed and if no confident diagnosis was obtained, patients were closely followed to rule out HCC. Final diagnosis was: HCC (n = 119), cholangiocarcinoma (n = 3), neuroendocrine tumour (n = 1) and benign lesions (n = 45). Results: CEUS did not detect contrast hyperenhancement in the arterial phase in 55 cases (34%). Eighteen out of these 55 nodules were diagnosed as HCC. Non-CEUS hyperenhanced HCCs were more frequently well-differentiated than CEUS-hyperenhanced HCCs (p < 0.004). Fourteen patients were treated with ablation and 4 with resection. Ten (55.6%) patients experienced tumour recurrence after treatment, mostly distant, confirming their overt malignant profile. Conclusions: Absence of contrast hyperenhancement on CEUS during the arterial phase in nodules < 2 cm in a cirrhotic liver does not predict a less malignant profile. Accordingly, priority for diagnostic work-up and treatment should not differ according to contrast profiles on CEUS. (C) 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:150 / 155
页数:6
相关论文
共 37 条
  • [1] [Anonymous], 2012, J HEPATOL, V56, P908
  • [2] [Anonymous], 1995, HEPATOLOGY, V22, P983
  • [3] Bohle W, 2012, Ultraschall Med, V33, pE191, DOI 10.1055/s-0031-1282029
  • [4] Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma
    Bolondi, L
    Gaiani, S
    Celli, N
    Goffieri, R
    Grigioni, WF
    Leoni, S
    Venturi, AM
    Piscaglia, F
    [J]. HEPATOLOGY, 2005, 42 (01) : 27 - 34
  • [5] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [6] Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound
    Chen, Li-Da
    Xu, Hui-Xiong
    Xie, Xiao-Yan
    Xie, Xiao-Hua
    Xu, Zuo-Feng
    Liu, Guang-Jian
    Wang, Zhu
    Lin, Man-Xia
    Lu, Ming-De
    [J]. EUROPEAN RADIOLOGY, 2010, 20 (03) : 743 - 753
  • [7] Hepatic Resection Versus Radiofrequency Ablation for Very Early Stage Hepatocellular Carcinoma: A Markov Model Analysis
    Cho, Yun Ku
    Kim, Jae Kyun
    Kim, Wan Tae
    Chung, Jin Wook
    [J]. HEPATOLOGY, 2010, 51 (04) : 1284 - 1290
  • [8] Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver - Update 2012 A WFUMB-EFSUMB Initiative in Cooperation With Representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS
    Claudon, M.
    Dietrich, C. F.
    Choi, B. I.
    Cosgrove, D. O.
    Kudo, M.
    Nolsoe, C. P.
    Piscaglia, F.
    Wilson, S. R.
    Barr, R. G.
    Chammas, M. C.
    Chaubal, N. G.
    Chen, M. -H.
    Clevert, D. A.
    Correas, J. M.
    Ding, H.
    Forsberg, F.
    Fowlkes, J. B.
    Gibson, R. N.
    Goldberg, B. B.
    Lassau, N.
    Leen, E. L. S.
    Mattrey, R. F.
    Moriyasu, F.
    Solbiati, L.
    Weskott, H. -P.
    Xu, H. -X.
    [J]. ULTRASCHALL IN DER MEDIZIN, 2013, 34 (01): : 11 - 29
  • [9] Principles of Cancer Screening: Lessons From History and Study Design Issues
    Croswell, Jennifer M.
    Ransohoff, David F.
    Kramer, Barnett S.
    [J]. SEMINARS IN ONCOLOGY, 2010, 37 (03) : 202 - 215
  • [10] Hepatocellular Carcinoma (HCC) A Global Perspective
    Ferenci, Peter
    Fried, Michael
    Labrecque, Douglas
    Bruix, Jordi
    Sherman, Morris
    Omata, Masao
    Heathcote, Jenny
    Piratsivuth, Teehra
    Kew, Mike
    Otegbayo, Jesse A.
    Zheng, S. S.
    Sarin, S.
    Hamid, Saeed S.
    Modawi, Salma Barakat
    Fleig, Wolfgang
    Fedail, Suliman
    Thomson, Alan
    Khan, Aamir
    Malfertheiner, Peter
    Lau, George
    Carillo, Flair J.
    Krabshuis, Justus
    Le Mair, Anton
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (04) : 239 - 245